Black Rock Inc. Intra Cellular Therapies, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,077,758 shares of ITCI stock, worth $585 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,077,758

Previous 8,193,544 1.41%

Holding current value

$585 Million

Previous $587 Million 4.74%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$64.37 - $75.65 $7.45 Million - $8.76 Million	-115,786 Reduced 1.41%	8,077,758 $559 Million
Q4 2023 Feb 13, 2024	BUY	$46.37 - $73.65 $31.5 Million - $50 Million	678,693 Added 9.03%	8,193,544 $587 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $3.97 Million - $4.89 Million	-76,216 Reduced 1.0%	7,514,851 $391 Million
Q2 2023 Aug 11, 2023	BUY	$54.67 - $66.44 $17.6 Million - $21.4 Million	322,235 Added 4.43%	7,591,067 $481 Million
Q1 2023 May 12, 2023	SELL	$43.8 - $56.99 $7.94 Million - $10.3 Million	-181,329 Reduced 2.43%	7,268,832 $394 Million

Q4 2022 Feb 13, 2023	BUY	$44.07 - $54.45 $15.3 Million - $19 Million	348,111 Added 4.9%	7,450,161 $394 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $2.29 Million - $3.22 Million	53,693 Added 0.76%	7,102,050 $330 Million
Q2 2022 Aug 12, 2022	BUY	$43.0 - $65.64 $24.9 Million - $37.9 Million	577,940 Added 8.93%	7,048,357 $402 Million
Q1 2022 May 12, 2022	BUY	$38.74 - $62.09 $29 Million - $46.5 Million	748,651 Added 13.08%	6,470,417 $396 Million
Q4 2021 Feb 10, 2022	SELL	$35.2 - $53.42 $514,976 - $781,534	-14,630 Reduced 0.26%	5,721,766 $299 Million
Q3 2021 Nov 09, 2021	BUY	$28.72 - $42.49 $503,949 - $745,572	17,547 Added 0.31%	5,736,396 $214 Million
Q2 2021 Aug 11, 2021	BUY	$29.3 - $44.5 $168 Million - $254 Million	5,718,849 New	5,718,849 $233 Million

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

77.7M

Call Options Held

1.7M

Put Options Held

1.13M

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $6.84B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account